Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement

Meiho University Institutional Repository > 健康暨護理學院 > 美容系 > 期刊論文 > Item 987654321/1231

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/1231

题名:	Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement
作者:	Lee RJ;Wu JS;Juang RH;Wu YJ;Lin CY;Wu SY;Huang PR;Chu CH;Chin LT;Chen HM
关键词:	Human plasma;Fetal calf serum;Monoclonal antibody bank;Multiplexed antigen immunization strategy;Hybridoma
日期:	2010-09
上传时间:	2011-09-28T04:00:05Z (UTC)
摘要:	Prion diseases such as Bovine Spongiform Encephalopathy (BSE) and new variant Creutzfeldt-Jakob disease (nvCJD) have caused a major safety concern in cell cultures using fetal calf serum (FCS). In this study, we found that screened and tested human plasma (HP) obtained from blood centers may be an ideal alternate nutrient substitute to FCS for culturing hybridoma. In addition to the inherent safety, a ten-fold increase in the fusion efficiency has been observed if the HP was used as the nutrient supplement instead of FCS. Subsequently, a broader antibody repertoire may be recovered. The HP supplement was found to promote the growth of hybridoma cells but no impact on antibody secretion. Interestingly, this effect of enrichment was only observed for HP, but not plasma from other animals. Unidentified murine hybridoma cloning factors other than IL-6 may specifically reside in human blood.
關聯:	J Immunol Methods. 2010 Sep 30;361(1-2):89-97. Epub 2010 Aug 17
显示于类别:	[美容系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html	Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement	0Kb	HTML	2202	检视/开启

在MUIR中所有的数据项都受到原著作权保护.